Skip to main content
Top
Published in: Malaria Journal 1/2020

Open Access 01-12-2020 | Malaria | Case study

History of malaria control in Rwanda: implications for future elimination in Rwanda and other malaria-endemic countries

Authors: Corine Karema, Shawn Wen, Abigail Sidibe, Jennifer L. Smith, Roly Gosling, Emmanuel Hakizimana, Marcel Tanner, Abdisalan M. Noor, Allison Tatarsky

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

Malaria was first reported in Rwanda in the early 1900s with significant heterogeneity and volatility in transmission over subsequent decades. Here, a comprehensive literature review of malaria transmission patterns and control strategies in Rwanda between 1900 and 2018 is presented to provide insight into successes and challenges in the country and to inform the future of malaria control in Rwanda.

Methods

A systematic literature search of peer-reviewed publications (Web of Knowledge, PubMed, Google Scholar, and the World Health Organization Library (WHOLIS) and grey literature on malaria control in Rwanda between 1900 and 2019 was conducted with the following search terms: “malaria”“, “Rwanda”, “epidemiology”, “control”, “treatment”, and/or “prevention.” Reports and other relevant documents were also obtained from the Rwanda National Malaria Control Programme (NMCP). To inform this literature review and evidence synthesis, epidemiologic and intervention data were collated from NMCP and partner reports, the national routine surveillance system, and population surveys.

Results

Two hundred sixty-eight peer-reviewed publications and 56 grey literature items were reviewed, and information was extracted. The history of malaria control in Rwanda is thematically described here according to five phases: 1900 to 1954 before the launch of the Global Malaria Eradication Programme (GMEP); (2) Implementation of the GMEP from 1955 to 1969; (3) Post- GMEP to 1994 Genocide; (4) the re-establishment of malaria control from 1995 to 2005, and (5) current malaria control efforts from 2006 to 2018. The review shows that Rwanda was an early adopter of tools and approaches in the early 2000s, putting the country ahead of the curve and health systems reforms created an enabling environment for an effective malaria control programme. The last two decades have seen unprecedented investments in malaria in Rwanda, resulting in significant declines in disease burden from 2000 to 2011. However, in recent years, these gains appear to have reversed with increasing cases since 2012 although the country is starting to make progress again.

Conclusion

The review shows the impact and fragility of gains against malaria, even in the context of sustained health system development. Also, as shown in Rwanda, country malaria control programmes should be dynamic and adaptive to respond and address changing settings.
Appendix
Available only for authorised users
Literature
2.
go back to reference Karema C, Aregawi MW, Rukundo A, Kabayiza A, Mulindahabi M, Fall IS, et al. Trends in malaria cases, hospital admissions and deaths following scale-up of anti-malarial interventions, 2000–2010, Rwanda. Malar J. 2012;11:236.PubMedPubMedCentralCrossRef Karema C, Aregawi MW, Rukundo A, Kabayiza A, Mulindahabi M, Fall IS, et al. Trends in malaria cases, hospital admissions and deaths following scale-up of anti-malarial interventions, 2000–2010, Rwanda. Malar J. 2012;11:236.PubMedPubMedCentralCrossRef
3.
go back to reference Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, et al. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J. 2009;8:14.PubMedPubMedCentralCrossRef Otten M, Aregawi M, Were W, Karema C, Medin A, Bekele W, et al. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malar J. 2009;8:14.PubMedPubMedCentralCrossRef
4.
go back to reference Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, et al. Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda. Malar J. 2008;7:167.PubMedPubMedCentralCrossRef Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, et al. Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of community-based malaria control programme in rural Rwanda. Malar J. 2008;7:167.PubMedPubMedCentralCrossRef
7.
go back to reference Malaria OPDD, R. B. C. Ministry of Health. Rwanda Malaria case management guidelines, 2015. 2015. Malaria OPDD, R. B. C. Ministry of Health. Rwanda Malaria case management guidelines, 2015. 2015.
8.
go back to reference Sinka ME, Bangs MJ, Manguin S, Coetzee M, Mbogo CM, Hemingway J, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic precis. Parasit Vectors. 2010;3:117.PubMedPubMedCentralCrossRef Sinka ME, Bangs MJ, Manguin S, Coetzee M, Mbogo CM, Hemingway J, et al. The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic precis. Parasit Vectors. 2010;3:117.PubMedPubMedCentralCrossRef
9.
go back to reference Hakizimana E, Karema C, Munyakanage D, Iranzi G, Githure J, Tongren JE, et al. Susceptibility of Anopheles gambiae to insecticides used for malaria vector control in Rwanda. Malar J. 2016;15:582.PubMedPubMedCentralCrossRef Hakizimana E, Karema C, Munyakanage D, Iranzi G, Githure J, Tongren JE, et al. Susceptibility of Anopheles gambiae to insecticides used for malaria vector control in Rwanda. Malar J. 2016;15:582.PubMedPubMedCentralCrossRef
10.
go back to reference Ivorra C. Sante et Maladies au Rwanda. In Paludisme. Bruxelles: AGCD; 1982; pp. 427–447. Ivorra C. Sante et Maladies au Rwanda. In Paludisme. Bruxelles: AGCD; 1982; pp. 427–447.
11.
go back to reference Le Mattlet G. Kapfura ou le Kaffindo-findo. 1935;15:521–5. Le Mattlet G. Kapfura ou le Kaffindo-findo. 1935;15:521–5.
12.
go back to reference Munyantore S. Historique de la lutte antipaludique au Rwanda. Rev Med Rwandaise. 1989;21:14–28. Munyantore S. Historique de la lutte antipaludique au Rwanda. Rev Med Rwandaise. 1989;21:14–28.
13.
go back to reference Meyus H, Lips M, Caubergh H. The current state of the problem of highland malaria in Ruanda-Urundi. Ann Soc Belge Med Trop. 1962;42:771–82.PubMed Meyus H, Lips M, Caubergh H. The current state of the problem of highland malaria in Ruanda-Urundi. Ann Soc Belge Med Trop. 1962;42:771–82.PubMed
14.
go back to reference Schwetz J. Contribution à l’étude des Anopheles du Congo oriental (Lac Kivu, Lac Albert). Ann Soc Belge Med Trop. 1941;21:17–36. Schwetz J. Contribution à l’étude des Anopheles du Congo oriental (Lac Kivu, Lac Albert). Ann Soc Belge Med Trop. 1941;21:17–36.
15.
go back to reference Van Poucke G. A comparative study on the use of intramuscular chloroquine and quinine (as Quinimax) in the treatment of uncomplicated falciparum malaria in adults. East Afr Med J. 1979;56:158–62.PubMed Van Poucke G. A comparative study on the use of intramuscular chloroquine and quinine (as Quinimax) in the treatment of uncomplicated falciparum malaria in adults. East Afr Med J. 1979;56:158–62.PubMed
16.
go back to reference Sambo L. Health systems and primary health care in the African region. Afr Health Monitor. 2011;14:2–3. Sambo L. Health systems and primary health care in the African region. Afr Health Monitor. 2011;14:2–3.
17.
go back to reference Schwetz J. Recherche sur le paludisme dans les villages et les camps de la division du Mwoghwalu des mines d’or de Kilo (Congo Belge). Institut Colonial Belge. 1940; Memoires in 8eme. Schwetz J. Recherche sur le paludisme dans les villages et les camps de la division du Mwoghwalu des mines d’or de Kilo (Congo Belge). Institut Colonial Belge. 1940; Memoires in 8eme.
18.
go back to reference Jadin J, Fain A. Contribution to the study of malaria in high altitudes. Ann Soc Belge Med Trop. 1951;31:353–63.PubMed Jadin J, Fain A. Contribution to the study of malaria in high altitudes. Ann Soc Belge Med Trop. 1951;31:353–63.PubMed
19.
go back to reference Chardome M, Peel E, Lambrecht FL. Malaria in the Ruzizi valley. Ann Soc Belge Med Trop. 1953;33:371–5.PubMed Chardome M, Peel E, Lambrecht FL. Malaria in the Ruzizi valley. Ann Soc Belge Med Trop. 1953;33:371–5.PubMed
20.
go back to reference Vincke IH, Jadin JB. Contribution a l’etude de l’anophelisme en pays d’altitude. Ann Soc Belge Med Trop. 1911;26:483–500. Vincke IH, Jadin JB. Contribution a l’etude de l’anophelisme en pays d’altitude. Ann Soc Belge Med Trop. 1911;26:483–500.
21.
go back to reference Jadin JB. Rapport sur la campagne de dedetisation dans le territoire d’Astrida. Ann Soc Belge Med Trop. 1952;32:445–64.PubMed Jadin JB. Rapport sur la campagne de dedetisation dans le territoire d’Astrida. Ann Soc Belge Med Trop. 1952;32:445–64.PubMed
22.
go back to reference Ettling MB, Shepard DS. Economic cost of malaria in Rwanda. Trop Med Parasitol. 1991;42:214–8.PubMed Ettling MB, Shepard DS. Economic cost of malaria in Rwanda. Trop Med Parasitol. 1991;42:214–8.PubMed
23.
go back to reference Mafart Y, Pieron R, Melchior JC. [A new case of Plasmodium falciparum malaria resistance to chloroquine in Africa (Rwanda)](in French). Med Trop (Mars). 1981;41:677–80.PubMed Mafart Y, Pieron R, Melchior JC. [A new case of Plasmodium falciparum malaria resistance to chloroquine in Africa (Rwanda)](in French). Med Trop (Mars). 1981;41:677–80.PubMed
24.
go back to reference Charmot G, Amat-Roze JM, Rodhain F, Le Bras J, Coulaud JP. Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa. Ann Soc Belge Med Trop. 1991;71:187–97. Charmot G, Amat-Roze JM, Rodhain F, Le Bras J, Coulaud JP. Geographic approach to the epidemiology of chloroquine-resistance of Plasmodium falciparum in tropical Africa. Ann Soc Belge Med Trop. 1991;71:187–97.
25.
go back to reference Giboda M, Vanista J, Dastych P. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda. Trans R Soc Trop Med Hyg. 1988;82:383.PubMedCrossRef Giboda M, Vanista J, Dastych P. The first report of Plasmodium falciparum resistant to chloroquine plus sulphadoxine/pyrimethamine in Rwanda. Trans R Soc Trop Med Hyg. 1988;82:383.PubMedCrossRef
26.
go back to reference Gascon J, Soldevila M, Merlos A, Bada JL. Chloroquine and amodiaquine resistant falciparum malaria in Rwanda. Lancet. 1985;2:1072.PubMedCrossRef Gascon J, Soldevila M, Merlos A, Bada JL. Chloroquine and amodiaquine resistant falciparum malaria in Rwanda. Lancet. 1985;2:1072.PubMedCrossRef
27.
go back to reference Gascon J, Pluymaekaers J, Bada JL. Chloroquine-resistant falciparum malaria from Rwanda. Trans R Soc Trop Med Hyg. 1986;80:351.PubMedCrossRef Gascon J, Pluymaekaers J, Bada JL. Chloroquine-resistant falciparum malaria from Rwanda. Trans R Soc Trop Med Hyg. 1986;80:351.PubMedCrossRef
28.
go back to reference Allen S, Van de Perre P, Serufilira A, Lepage P, Carael M, DeClercq A, et al. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis. 1991;164:67–71.PubMedCrossRef Allen S, Van de Perre P, Serufilira A, Lepage P, Carael M, DeClercq A, et al. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis. 1991;164:67–71.PubMedCrossRef
29.
go back to reference Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, et al. Rwanda 20 years on: investing in life. Lancet. 2014;384:371–5.PubMedPubMedCentralCrossRef Binagwaho A, Farmer PE, Nsanzimana S, Karema C, Gasana M, de Dieu Ngirabega J, et al. Rwanda 20 years on: investing in life. Lancet. 2014;384:371–5.PubMedPubMedCentralCrossRef
30.
go back to reference Musafili A, Essen B, Baribwira C, Binagwaho A, Persson L-A, Selling KE. Trends and social differentials in child mortality in Rwanda 1990–2010: results from three demographic and health surveys. J Epidemiol Community Health. 2015;69:834–40.PubMedCrossRef Musafili A, Essen B, Baribwira C, Binagwaho A, Persson L-A, Selling KE. Trends and social differentials in child mortality in Rwanda 1990–2010: results from three demographic and health surveys. J Epidemiol Community Health. 2015;69:834–40.PubMedCrossRef
32.
go back to reference Overseas Development Institute. Overseas Development Institute annual report 2010–2011. Overseas Development Institute, 2012. Overseas Development Institute. Overseas Development Institute annual report 2010–2011. Overseas Development Institute, 2012.
33.
34.
go back to reference Cooperation Belge au developpement. evaluation de l’appui du Prgramme integre de lutte contre le Paludisme au Rwanda1994–2006. 2008. Cooperation Belge au developpement. evaluation de l’appui du Prgramme integre de lutte contre le Paludisme au Rwanda1994–2006. 2008.
35.
go back to reference Hammerich A, Campbell OMR, Chandramohan D. Unstable malaria transmission and maternal mortality–experiences from Rwanda. Trop Med Int Health. 2002;7:573–6.PubMedCrossRef Hammerich A, Campbell OMR, Chandramohan D. Unstable malaria transmission and maternal mortality–experiences from Rwanda. Trop Med Int Health. 2002;7:573–6.PubMedCrossRef
37.
go back to reference Rwagacondo CE, Karema C, Mugisha V, Erhart A, Dujardin JC, Overmeir CV, et al. Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Trop Med Int Health. 2004;9:1091–8.PubMedCrossRef Rwagacondo CE, Karema C, Mugisha V, Erhart A, Dujardin JC, Overmeir CV, et al. Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Trop Med Int Health. 2004;9:1091–8.PubMedCrossRef
38.
go back to reference Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, et al. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg. 2003;68:743–7.PubMedCrossRef Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, et al. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate. Am J Trop Med Hyg. 2003;68:743–7.PubMedCrossRef
39.
go back to reference EANMAT. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health. 2001;6:891–8.CrossRef EANMAT. Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health. 2001;6:891–8.CrossRef
41.
go back to reference Van Geertruyden J-P, Ntakirutimana D, Erhart A, Rwagacondo C, Kabano A, D’Alessandro U. Malaria infection among pregnant women attending antenatal clinics in six Rwandan districts. Trop Med Int Health. 2005;10:681–8.PubMedCrossRef Van Geertruyden J-P, Ntakirutimana D, Erhart A, Rwagacondo C, Kabano A, D’Alessandro U. Malaria infection among pregnant women attending antenatal clinics in six Rwandan districts. Trop Med Int Health. 2005;10:681–8.PubMedCrossRef
42.
go back to reference Mugeni C, Levine AC, Munyaneza RM, Mulindahabi E, Cockrell HC, Glavis-Bloom J, et al. Nationwide implementation of integrated community case management of childhood illness in Rwanda. Glob health, Sci Pract. 2014;2:328–41.CrossRef Mugeni C, Levine AC, Munyaneza RM, Mulindahabi E, Cockrell HC, Glavis-Bloom J, et al. Nationwide implementation of integrated community case management of childhood illness in Rwanda. Glob health, Sci Pract. 2014;2:328–41.CrossRef
44.
go back to reference Logie DE, Rowson M, Ndagije F. Innovations in Rwanda’s health system: looking to the future. Lancet. 2008;372:256–61.PubMedCrossRef Logie DE, Rowson M, Ndagije F. Innovations in Rwanda’s health system: looking to the future. Lancet. 2008;372:256–61.PubMedCrossRef
45.
go back to reference Kalk A, Paul FA, Grabosch E. ‘Paying for performance’in Rwanda: does it pay off? Trop Med Int Health. 2010;15:182–90.PubMedCrossRef Kalk A, Paul FA, Grabosch E. ‘Paying for performance’in Rwanda: does it pay off? Trop Med Int Health. 2010;15:182–90.PubMedCrossRef
46.
go back to reference Schmidt JO, Mayindo JK, Kalk A. Thresholds for health insurance in Rwanda: who should pay how much? Trop Med Int Health. 2006;11:1327–33.PubMedCrossRef Schmidt JO, Mayindo JK, Kalk A. Thresholds for health insurance in Rwanda: who should pay how much? Trop Med Int Health. 2006;11:1327–33.PubMedCrossRef
47.
go back to reference Overseas Development Institute- Development progress. Rwanda’s progress in health: Leadership, performance and insurance. In Development Progress, Overseas Development Institute. London, UK2011. pp. 1–38. Overseas Development Institute- Development progress. Rwanda’s progress in health: Leadership, performance and insurance. In Development Progress, Overseas Development Institute. London, UK2011. pp. 1–38.
48.
go back to reference Nisr M, Macro O. USARwanda demographic and health survey 2010. Calverton: National Institute of Statistics of Rwanda, Ministry of Health, Kigali, and ORC Macro International; 2012. Nisr M, Macro O. USARwanda demographic and health survey 2010. Calverton: National Institute of Statistics of Rwanda, Ministry of Health, Kigali, and ORC Macro International; 2012.
49.
go back to reference Malaria OPDD, R. B. C. Ministry of Health, Jhpiego Rwanda. Malaria prevalence iamong pregnant Rwandan women—Study report. 2014. Malaria OPDD, R. B. C. Ministry of Health, Jhpiego Rwanda. Malaria prevalence iamong pregnant Rwandan women—Study report. 2014.
53.
go back to reference Malaria opDD, R. B. C. Rwanda annual malaria report 2015. 2015. Malaria opDD, R. B. C. Rwanda annual malaria report 2015. 2015.
54.
go back to reference Barat L, Schubert J. External Evaluation of the Pilot Phase of the Home-Based Management of Malaria Program in Rwanda, Final Report. Kigali: USAID/BASICS, USAID/RPM Plus, Integrated National Malaria Control Program, Rwanda. 2007. Barat L, Schubert J. External Evaluation of the Pilot Phase of the Home-Based Management of Malaria Program in Rwanda, Final Report. Kigali: USAID/BASICS, USAID/RPM Plus, Integrated National Malaria Control Program, Rwanda. 2007.
55.
go back to reference Franco C, Schubert J, Yameogo M, Briggs J, Kabuya W, Hitayezu F, et al. Evaluation of the Home Based Management of Malaria Strategy in Rwanda: 2008. Arlington: BASICS, SPS, USAID; 2008. Franco C, Schubert J, Yameogo M, Briggs J, Kabuya W, Hitayezu F, et al. Evaluation of the Home Based Management of Malaria Strategy in Rwanda: 2008. Arlington: BASICS, SPS, USAID; 2008.
57.
go back to reference Karema C, Imwong M, Fanello CI, Stepniewska K, Uwimana A, Nakeesathit S, et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2010;54:477–83.PubMedCrossRef Karema C, Imwong M, Fanello CI, Stepniewska K, Uwimana A, Nakeesathit S, et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2010;54:477–83.PubMedCrossRef
58.
go back to reference Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ, et al. High risk of severe anaemia after chlorproguanil-dapsone + artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS ONE. 2008;3:e4031.PubMedPubMedCentralCrossRef Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ, et al. High risk of severe anaemia after chlorproguanil-dapsone + artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS ONE. 2008;3:e4031.PubMedPubMedCentralCrossRef
59.
go back to reference Fanello CI, Karema C, van Doren W, Rwagacondo CE, D’Alessandro U. Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults. Trop Med Int Health. 2006;11:589–96.PubMedCrossRef Fanello CI, Karema C, van Doren W, Rwagacondo CE, D’Alessandro U. Tolerability of amodiaquine and sulphadoxine-pyrimethamine, alone or in combination for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan adults. Trop Med Int Health. 2006;11:589–96.PubMedCrossRef
63.
go back to reference Clinton Health Access Initiative. Maintaining the Gains in Global Malaria Control. 2013. Clinton Health Access Initiative. Maintaining the Gains in Global Malaria Control. 2013.
64.
go back to reference National Institute of Statistics of Rwanda (NISR) [Rwanda], MoHMR, International aI. Rwanda Demographic and Health Survey 2014–15. ICF International edition. pp. 513. 530 Gaither Road, Suite 500, Rockville, MD 20850, USA, National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MOH) [Rwanda], and ICF International. 2015, 2016,513. https://www.dhsprogram.com/what-we-do/survey/survey-display-468.cfm. National Institute of Statistics of Rwanda (NISR) [Rwanda], MoHMR, International aI. Rwanda Demographic and Health Survey 2014–15. ICF International edition. pp. 513. 530 Gaither Road, Suite 500, Rockville, MD 20850, USA, National Institute of Statistics of Rwanda (NISR) [Rwanda], Ministry of Health (MOH) [Rwanda], and ICF International. 2015, 2016,513. https://​www.​dhsprogram.​com/​what-we-do/​survey/​survey-display-468.​cfm.
66.
go back to reference Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, et al. Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of a community-based malaria control programme in rural Rwanda. World Hosp Health Serv. 2008;44:28–35.PubMed Sievers AC, Lewey J, Musafiri P, Franke MF, Bucyibaruta BJ, Stulac SN, et al. Reduced paediatric hospitalizations for malaria and febrile illness patterns following implementation of a community-based malaria control programme in rural Rwanda. World Hosp Health Serv. 2008;44:28–35.PubMed
67.
go back to reference Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH. From malaria control to eradication: the WHO perspective. Trop Med Int Health. 2009;14:802–9.PubMedCrossRef Mendis K, Rietveld A, Warsame M, Bosman A, Greenwood B, Wernsdorfer WH. From malaria control to eradication: the WHO perspective. Trop Med Int Health. 2009;14:802–9.PubMedCrossRef
68.
go back to reference Bucagu M, Kagubare JM, Basinga P, Ngabo F, Timmons BK, Lee AC. Impact of health systems strengthening on coverage of maternal health services in Rwanda, 2000–2010: a systematic review. Reprod Health Matters. 2012;20:50–61.PubMedCrossRef Bucagu M, Kagubare JM, Basinga P, Ngabo F, Timmons BK, Lee AC. Impact of health systems strengthening on coverage of maternal health services in Rwanda, 2000–2010: a systematic review. Reprod Health Matters. 2012;20:50–61.PubMedCrossRef
69.
70.
go back to reference Sekabaraga C, Diop F, Soucat A. Can innovative health financing policies increase access to MDG-related services? Evidence from Rwanda. Health Policy Plan. 2011;26:ii52–62.PubMed Sekabaraga C, Diop F, Soucat A. Can innovative health financing policies increase access to MDG-related services? Evidence from Rwanda. Health Policy Plan. 2011;26:ii52–62.PubMed
71.
go back to reference National Institute of Statistics of RRMo, Health and ICF International,. Rwanda DHS 2014–15: Key Indicators. DHS Macro, 2015. National Institute of Statistics of RRMo, Health and ICF International,. Rwanda DHS 2014–15: Key Indicators. DHS Macro, 2015.
74.
go back to reference Loevinsohn ME. Climatic warming and increased malaria incidence in Rwanda. Lancet. 1994;343:714–8.PubMedCrossRef Loevinsohn ME. Climatic warming and increased malaria incidence in Rwanda. Lancet. 1994;343:714–8.PubMedCrossRef
75.
go back to reference Lindsay S, Zetocha. A feasible approach for implementing greater levels of satellite autonomy. In AIAA Defense and Civil Space Programs Conference and Exhibit. 1998: 5232. Lindsay S, Zetocha. A feasible approach for implementing greater levels of satellite autonomy. In AIAA Defense and Civil Space Programs Conference and Exhibit. 1998: 5232.
76.
78.
go back to reference Binagwaho A, Freeman R, Scott K, Harward S, Mulindahabi M, Karema C. Improving international accountability—a tool for protecting health as a basic human right. Health Hum Rights. April 2015. Accessed 20 August 2015. Binagwaho A, Freeman R, Scott K, Harward S, Mulindahabi M, Karema C. Improving international accountability—a tool for protecting health as a basic human right. Health Hum Rights. April 2015. Accessed 20 August 2015.
79.
go back to reference Hakizimana E, Cyubahiro B, Rukundo A, Kabayiza A, Mutabazi A, Beach R, et al. Monitoring long-lasting insecticidal net (LLIN) durability to validate net serviceable life assumptions, in Rwanda. Malar J. 2014;13:344.PubMedPubMedCentralCrossRef Hakizimana E, Cyubahiro B, Rukundo A, Kabayiza A, Mutabazi A, Beach R, et al. Monitoring long-lasting insecticidal net (LLIN) durability to validate net serviceable life assumptions, in Rwanda. Malar J. 2014;13:344.PubMedPubMedCentralCrossRef
80.
go back to reference Malaria OPDD, R. B. C. Ministry of Health,. Rwanda Malaria Program Review 2019. RBC, 2019. Malaria OPDD, R. B. C. Ministry of Health,. Rwanda Malaria Program Review 2019. RBC, 2019.
81.
go back to reference Constanza T, PranbanjaN PG, Bayingana C, Sifft KC, Geus D, Ndoli J, et al. Artemisinin resistance–associated K13 polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015. Am J Trop Med Hyg. 2016;95:1090–3.CrossRef Constanza T, PranbanjaN PG, Bayingana C, Sifft KC, Geus D, Ndoli J, et al. Artemisinin resistance–associated K13 polymorphisms of Plasmodium falciparum in Southern Rwanda, 2010–2015. Am J Trop Med Hyg. 2016;95:1090–3.CrossRef
Metadata
Title
History of malaria control in Rwanda: implications for future elimination in Rwanda and other malaria-endemic countries
Authors
Corine Karema
Shawn Wen
Abigail Sidibe
Jennifer L. Smith
Roly Gosling
Emmanuel Hakizimana
Marcel Tanner
Abdisalan M. Noor
Allison Tatarsky
Publication date
01-12-2020
Publisher
BioMed Central
Keyword
Malaria
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03407-1

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue